医療用スキンケア市場：製品タイプ別、有効成分別、包装タイプ別、適応症別、流通チャネル別、収益分布 - 2025年～2030年世界予測

医療用スキンケア市場は、2023年に968億2,000万米ドルと評価され、2024年には1,043億米ドルに達すると予測され、CAGR 8.19％で成長し、2030年には1,680億6,000万米ドルに達すると予測されています。

医療用スキンケアは、市販の製品よりも高濃度の有効成分を配合し、特定の肌状態をターゲットに設計された、有効性が実証された製品のカテゴリーです。医療用スキンケアの必要性は、ニキビ、色素沈着、老化など、従来のスキンケア製品では不十分な問題に対する効果的な解決策を求める消費者の需要に起因しています。これらの製品は、皮膚科クリニックからメッドスパに至るまで、様々な場面で使用され、科学的に検証された結果を得るためにヘルスケア専門家によって推奨されることが多いです。最終用途の範囲は、治療的ニーズと美容的ニーズの両方に及び、新たな肌悩みの予防対策にもなります。市場の成長は主に、スキンケアの利点に関する消費者の認識と教育の高まり、高級製品への投資を可能にする可処分所得の増加、成分デリバリー・システムの技術的進歩の影響を受けています。しかし、規制上の課題や製品開発コストの高さが制約となる可能性があります。さらに、医薬部外品や偽造品との競合は、市場の成長に悪影響を及ぼす可能性があります。

現在のビジネスチャンスを活用するために、企業は天然でありながら強力な有効成分を統合することで、クリーンな美容動向を活用することに注力すべきです。AIと機械学習による洞察によって開発されたパーソナライズド・スキンケア・ソリューションは、個人の肌ニーズにきめ細かく対応する最先端の手段を提供します。企業はまた、流通チャネルを拡大するためにヘルスケアプロバイダーとの提携を模索すべきです。臨床試験や透明性の高いマーケティング戦略への投資は、消費者の信頼と信用を高める可能性があります。市場は、競争優位性を維持するために、特に製剤科学と持続可能なパッケージングにおいて、絶え間ないイノベーションを求めています。厳しいコンプライアンスへの対応や、効能効果に関する消費者の懐疑的な見方を克服するといった課題も残っています。結局のところ、この医療用スキンケアセクターは、より広範な健康・ウェルネス動向との強い相関関係から利益を得ており、科学的研究を商業的成功に活用することに長けた企業にとって、大きな可能性を示唆しています。

市場力学：急速に進化する医療用スキンケア市場の主要市場インサイトを公開

医療用スキンケア市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

ポーターのファイブフォース：医療用スキンケア市場をナビゲートする戦略ツール

ポーターのファイブフォースは、医療用スキンケア市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医療用スキンケア市場における外部からの影響の把握

外部マクロ環境要因は、医療用スキンケア市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：医療用スキンケア市場における競合情勢の把握

医療用スキンケア市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：医療用スキンケア市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医療用スキンケア市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビューをします。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肌の健康の重要性に関する消費者の傾向と意識の高まり
    • 非外科的美容処置と医療用スキンケア製品利用の人気の高まり
  • 抑制要因
    • 医療用スキンケア製品に関する消費者の認知度が低い
  • 機会
    • 新しい医療用スキンケア製品と処方の開発
    • 医療用スキンケア製品のオンラインチャネルでのアクセス性と入手可能性を拡大
  • 課題
    • 皮膚への悪影響による製品の潜在的なリスク
• 市場セグメンテーション分析
  • 製品：さまざまな肌タイプに合う医療用スキンケア商品の需要が高まる
  • 有効成分：ヒアルロン酸の驚くべき水分保持能力による成長の可能性
  • 包装タイプ：利便性と使いやすさからチューブタイプの医療用スキンケア製品への傾向が高まっている
  • 適応症：毛穴の詰まりを取り除き、炎症を軽減するニキビ管理のための医療グレードのスキンケア製品の使用増加
  • 流通チャネル：利便性と幅広い選択肢を提供するオンラインプラットフォームで医療用スキンケア製品がますます入手しやすくなっている
  • 収益分配：医療用スキンケアの消費量の増加に伴い、販売収益が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
  • 法的
  • 環境的

第6章 医療用スキンケア市場：製品別

• クレンザー
• ジェル、クリーム、保湿剤
• マスク・美容液

第7章 医療用スキンケア市場：有効成分別

• アルファヒドロキシ酸
• セラミド
• フェルラ酸
• ヒアルロン酸
• コウジ酸
• サリチル酸
• ビタミン
  • ビタミンA
  • ビタミンB
  • ビタミンC
  • ビタミンE
  • ビタミンK

第8章 医療用スキンケア市場：包装タイプ別

• ボトル
• ディスペンシングポンプ
• チューブ

第9章 医療用スキンケア市場：適応症別

• ニキビ
• シミ
• 乾燥肌
• 小じわとシワ
• 色素沈着
• 皮膚のたるみ
• 日焼けによるダメージ

第10章 医療用スキンケア市場：流通チャネル別

• オフライン
  • 皮膚科クリニック
  • 医師
• オンライン

第11章 医療用スキンケア市場：収益分布別

• 売り込み
• 売り切れ

第12章 南北アメリカの医療用スキンケア市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の医療用スキンケア市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの医療用スキンケア市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • ShiseidoがDr. Dennis Gross Skincareを買収
  • Revision Skincareが新しい革新とともに「Science Is Black and White」ブランドキャンペーンを発表
  • Galdermaが英国での発売とカナダでの直接流通および拡大を発表
  • INSKIN COSMEDICSが成長を加速させるための資金調達に成功
  • Alumierが最新のリファイニングクレイマスクを発表
  • Skin Pharmが1,500万米ドルを調達し、クリニックの拡大と美容皮膚科のスケールアップを目指す
  • Skin RxがZ世代向けの予防的な医療グレードのスキンケアを発売
  • Hand & Stoneがスキンケアとフェイシャルエンハンスメントにさらに投資
  • GetHarleyが5,200万米ドルを調達し、消費者を世界クラスの臨床医や医療グレードのスキンケア製品とつなぐ
  • AlumierMDが新しいウェルネス資産を発表
  • 英国拠点のSkin + Meが、パーソナライズされた処方ベースのスキンケアアプローチのために1,100万ユーロ以上を調達
  • Evolve Med Spaが医療グレードのスキンケアラインを発売

企業一覧

• Abbott Laboratories
• ALASTIN Skincare, Inc. by Galderma Laboratories, L.P.
• Alkem Laboratories Ltd.
• AllerganAesthetics
• Alpyn Beauty
• AlumierMD Labs, Inc.
• AMP Medical, LLC
• Aspect Skincare by Advanced Skin Technology Pty Ltd.
• Audaja Inc.
• Augustinus Bader
• Beiersdorf AG
• Bioderma
• Cipla Limited
• Colgate-Palmolive Company
• CosMedical Technologies
• Cosmetic Solutions
• DefenAge by Progenitor Biologics, LLC
• DERMAdoctor, LLC by NovaBay Pharmaceuticals
• Eau Thermale Avene by Pierre Fabre Group
• Environ Skin Care（Pty）Ltd.
• Epicutis
• Episciences, Inc.
• ESK Care Pty Limited
• Estee Lauder Companies Inc.
• Evolve Med Spa
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Limited
• Honasa Consumer Ltd.
• Image Skincare
• INSKIN Cosmedics Group Pty Ltd.
• Inspira Skin
• iS Clinical
• Jan Marini Skin Research
• L'Oreal S.A.
• NEOCUTIS by Merz North America, Inc.
• NeoStrata Company, Inc. by Johnson & Johnson Services, Inc.
• Obagi Cosmeceuticals LLC
• Piramal Pharma Limited
• Revision Skincare
• Sebapharma GmbH & CO. KG
• Sente, Inc.
• Shiseido Company, Limited
• Skin+Me
• The Skincare Company
• Topix Pharmaceuticals, Inc.
• Trilogy Laboratories, LLC
• Unilever PLC
• USRx LLC
• ZO Skin Health, Inc.

LIST OF FIGURES

• FIGURE 1. MEDICAL GRADE SKINCARE MARKET RESEARCH PROCESS
• FIGURE 2. MEDICAL GRADE SKINCARE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. MEDICAL GRADE SKINCARE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. MEDICAL GRADE SKINCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MEDICAL GRADE SKINCARE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MEDICAL GRADE SKINCARE MARKET DYNAMICS
• TABLE 7. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY CLEANSERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY GELS, CREAMS & MOISTURIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY MASKS & SERUMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY ALPHA HYDROXY ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY CERAMIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY FERULIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY KOJIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY SALICYLIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMIN A, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMIN B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMIN C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMIN E, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMIN K, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY BOTTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY DISPENSING PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY TUBE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY ACNE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY AGE SPOTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY DRY SKIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY FINE LINES & WINKLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY HYPERPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY SKIN LAXITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY SUN DAMAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY PHYSICIANS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY SELL-IN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL MEDICAL GRADE SKINCARE MARKET SIZE, BY SELL-OUT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 71. CANADA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CANADA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 73. CANADA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 74. CANADA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 75. CANADA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. CANADA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 77. CANADA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 78. CANADA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. AUSTRALIA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 107. AUSTRALIA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 113. CHINA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. CHINA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 115. CHINA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 116. CHINA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 117. CHINA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. CHINA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 119. CHINA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 120. CHINA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 121. INDIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. INDIA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 123. INDIA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 124. INDIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 125. INDIA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. INDIA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 127. INDIA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 128. INDIA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 129. INDONESIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. INDONESIA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 131. INDONESIA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 132. INDONESIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. INDONESIA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 137. JAPAN MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. JAPAN MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 139. JAPAN MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 140. JAPAN MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. JAPAN MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 143. JAPAN MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 145. MALAYSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. MALAYSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 147. MALAYSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 148. MALAYSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. MALAYSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 151. MALAYSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 152. MALAYSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 153. PHILIPPINES MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. PHILIPPINES MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 155. PHILIPPINES MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 156. PHILIPPINES MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 157. PHILIPPINES MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 158. PHILIPPINES MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 159. PHILIPPINES MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 160. PHILIPPINES MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 161. SINGAPORE MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SINGAPORE MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 163. SINGAPORE MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 164. SINGAPORE MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SINGAPORE MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 166. SINGAPORE MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 167. SINGAPORE MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 168. SINGAPORE MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH KOREA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH KOREA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH KOREA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH KOREA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH KOREA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 177. TAIWAN MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. TAIWAN MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 179. TAIWAN MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 180. TAIWAN MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TAIWAN MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. TAIWAN MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 183. TAIWAN MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 184. TAIWAN MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 185. THAILAND MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. THAILAND MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 187. THAILAND MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 188. THAILAND MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 189. THAILAND MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. THAILAND MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 191. THAILAND MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 192. THAILAND MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 193. VIETNAM MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. VIETNAM MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 195. VIETNAM MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 196. VIETNAM MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 197. VIETNAM MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 198. VIETNAM MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 199. VIETNAM MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 200. VIETNAM MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 210. DENMARK MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. DENMARK MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 212. DENMARK MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 213. DENMARK MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 214. DENMARK MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 215. DENMARK MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 216. DENMARK MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 217. DENMARK MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 218. EGYPT MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. EGYPT MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 220. EGYPT MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 221. EGYPT MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 222. EGYPT MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 223. EGYPT MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 224. EGYPT MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 225. EGYPT MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 226. FINLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. FINLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 228. FINLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 229. FINLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 230. FINLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 231. FINLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 232. FINLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 233. FINLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 234. FRANCE MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. FRANCE MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 236. FRANCE MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 237. FRANCE MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 238. FRANCE MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 239. FRANCE MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 240. FRANCE MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 241. FRANCE MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 242. GERMANY MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 243. GERMANY MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 244. GERMANY MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 245. GERMANY MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 246. GERMANY MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 247. GERMANY MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 248. GERMANY MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 249. GERMANY MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 250. ISRAEL MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 251. ISRAEL MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 252. ISRAEL MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 253. ISRAEL MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 254. ISRAEL MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 255. ISRAEL MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 256. ISRAEL MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 257. ISRAEL MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 258. ITALY MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. ITALY MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 260. ITALY MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 261. ITALY MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 262. ITALY MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 263. ITALY MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 264. ITALY MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 265. ITALY MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 266. NETHERLANDS MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 267. NETHERLANDS MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 268. NETHERLANDS MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 269. NETHERLANDS MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 270. NETHERLANDS MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 271. NETHERLANDS MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 272. NETHERLANDS MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 273. NETHERLANDS MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 274. NIGERIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. NIGERIA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 276. NIGERIA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 277. NIGERIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 278. NIGERIA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 279. NIGERIA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 280. NIGERIA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 281. NIGERIA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 282. NORWAY MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. NORWAY MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 284. NORWAY MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 285. NORWAY MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 286. NORWAY MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 287. NORWAY MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 288. NORWAY MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 289. NORWAY MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 290. POLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 291. POLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 292. POLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 293. POLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 294. POLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 295. POLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 296. POLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 297. POLAND MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 298. QATAR MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 299. QATAR MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 300. QATAR MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 301. QATAR MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 302. QATAR MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 303. QATAR MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 304. QATAR MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 305. QATAR MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 306. RUSSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 307. RUSSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 308. RUSSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 309. RUSSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 310. RUSSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 311. RUSSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 312. RUSSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 313. RUSSIA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 314. SAUDI ARABIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 316. SAUDI ARABIA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 318. SAUDI ARABIA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 319. SAUDI ARABIA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 320. SAUDI ARABIA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 321. SAUDI ARABIA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 322. SOUTH AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 324. SOUTH AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 325. SOUTH AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 326. SOUTH AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 327. SOUTH AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 328. SOUTH AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 329. SOUTH AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 330. SPAIN MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 331. SPAIN MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2018-2030 (USD MILLION)
• TABLE 332. SPAIN MEDICAL GRADE SKINCARE MARKET SIZE, BY VITAMINS, 2018-2030 (USD MILLION)
• TABLE 333. SPAIN MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 334. SPAIN MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)

TABLE 33

The Medical Grade Skincare Market was valued at USD 96.82 billion in 2023, expected to reach USD 104.30 billion in 2024, and is projected to grow at a CAGR of 8.19%, to USD 168.06 billion by 2030.

Medical grade skincare is a category of products that are formulated with higher concentrations of active ingredients compared to over-the-counter options, designed to target specific skin conditions with proven efficacy. The necessity for medical grade skincare stems from consumer demand for effective solutions to issues such as acne, hyperpigmentation, and aging, where traditional skincare products fall short. These products are applied in settings ranging from dermatology clinics to med-spas and are often recommended by healthcare professionals for their scientifically validated results. The end-use scope spans both therapeutic and cosmetic needs, as well as preventative measures for emerging skin concerns. The market's growth is primarily influenced by increasing consumer awareness and education on skincare benefits, rising disposable income allowing for investment in premium products, and technological advancements in ingredient delivery systems. However, regulatory challenges and the high cost of product development can pose limitations. Moreover, competition from non-medical counterparts and counterfeit products can impact market growth adversely.

To capitalize on current opportunities, businesses should focus on harnessing clean beauty trends by integrating natural yet potent active ingredients. Personalized skincare solutions, developed through AI and machine learning insights, present a cutting-edge avenue to cater to individual skin needs meticulously. Companies should also seek partnerships with healthcare providers to expand distribution channels. Investing in clinical trials and transparent marketing strategies could enhance consumer trust and credibility. The market demands continuous innovation, especially in formulation science and sustainable packaging, to maintain competitive advantage. Challenges such as navigating strict compliance and overcoming consumer skepticism regarding efficacy claims remain. Ultimately, the medical grade skincare sector benefits from a strong correlation with broader health and wellness trends, suggesting robust potential for companies adept at leveraging scientific research into commercial success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Grade Skincare Market

The Medical Grade Skincare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing consumer inclination and awareness regarding the importance of skin health
  • Growing popularity of nonsurgical aesthetic procedures and utilization of medical grade skincare products
• Market Restraints
  • Limited consumer awareness associated with medical grade skincare products
• Market Opportunities
  • Development of new medical grade skincare products and formulations
  • Expanding accessibility and availability of medical grade skincare products on online channels
• Market Challenges
  • Possible risks of products due to negative reactions to skin

Porter's Five Forces: A Strategic Tool for Navigating the Medical Grade Skincare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Grade Skincare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Grade Skincare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Grade Skincare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Grade Skincare Market

A detailed market share analysis in the Medical Grade Skincare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Grade Skincare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Grade Skincare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Medical Grade Skincare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALASTIN Skincare, Inc. by Galderma Laboratories, L.P., Alkem Laboratories Ltd., AllerganAesthetics, Alpyn Beauty, AlumierMD Labs, Inc., AMP Medical, LLC, Aspect Skincare by Advanced Skin Technology Pty Ltd., Audaja Inc., Augustinus Bader, Beiersdorf AG, Bioderma, Cipla Limited, Colgate-Palmolive Company, CosMedical Technologies, Cosmetic Solutions, DefenAge by Progenitor Biologics, LLC, DERMAdoctor, LLC by NovaBay Pharmaceuticals, Eau Thermale Avene by Pierre Fabre Group, Environ Skin Care (Pty) Ltd., Epicutis, Episciences, Inc., ESK Care Pty Limited, Estee Lauder Companies Inc., Evolve Med Spa, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Honasa Consumer Ltd., Image Skincare, INSKIN Cosmedics Group Pty Ltd., Inspira Skin, iS Clinical, Jan Marini Skin Research, L'Oreal S.A., NEOCUTIS by Merz North America, Inc., NeoStrata Company, Inc. by Johnson & Johnson Services, Inc., Obagi Cosmeceuticals LLC, Piramal Pharma Limited, Revision Skincare, Sebapharma GmbH & CO. KG, Sente, Inc., Shiseido Company, Limited, Skin + Me, The Skincare Company, Topix Pharmaceuticals, Inc., Trilogy Laboratories, LLC, Unilever PLC, USRx LLC, and ZO Skin Health, Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Grade Skincare Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cleansers, Gels, Creams & Moisturizers, and Masks & Serums.
• Based on Active Ingredients, market is studied across Alpha Hydroxy Acids, Ceramides, Ferulic Acid, Hyaluronic Acid, Kojic Acid, Salicylic Acid, and Vitamins. The Vitamins is further studied across Vitamin A, Vitamin B, Vitamin C, Vitamin E, and Vitamin K.
• Based on Packaging Type, market is studied across Bottle, Dispensing Pumps, and Tube.
• Based on Indication, market is studied across Acne, Age Spots, Dry Skin, Fine Lines & Winkles, Hyperpigmentation, Skin Laxity, and Sun Damage.
• Based on Distribution Channels, market is studied across Offline and Online. The Offline is further studied across Dermatology Clinics and Physicians.
• Based on Revenue Distribution, market is studied across Sell-in and Sell-out.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing consumer inclination and awareness regarding the importance of skin health
    • 5.1.1.2. Growing popularity of nonsurgical aesthetic procedures and utilization of medical grade skincare products
  • 5.1.2. Restraints
    • 5.1.2.1. Limited consumer awareness associated with medical grade skincare products
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of new medical grade skincare products and formulations
    • 5.1.3.2. Expanding accessibility and availability of medical grade skincare products on online channels
  • 5.1.4. Challenges
    • 5.1.4.1. Possible risks of products due to negative reactions to skin
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising demand for medical grade skincare products which can suit various skin types
  • 5.2.2. Active Ingredients: Growing potential of hyaluronic acid due to its incredible capacity to retain moisture
  • 5.2.3. Packaging Type: Increasing inclination towards dispensing tube-type medical grade skincare products due to its convenience and ease of use
  • 5.2.4. Indication: Rising usage of medical grade skin care products to manage acne that helps to unclog pores and reduce inflammation
  • 5.2.5. Distribution Channels: Growing availability of medical grade skincare products across online platforms as they offer convenience and broader selection
  • 5.2.6. Revenue Distribution: Rising sell-out revenue with increasing consumption of medical grade skincare
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Medical Grade Skincare Market, by Product

• 6.1. Introduction
• 6.2. Cleansers
• 6.3. Gels, Creams & Moisturizers
• 6.4. Masks & Serums

7. Medical Grade Skincare Market, by Active Ingredients

• 7.1. Introduction
• 7.2. Alpha Hydroxy Acids
• 7.3. Ceramides
• 7.4. Ferulic Acid
• 7.5. Hyaluronic Acid
• 7.6. Kojic Acid
• 7.7. Salicylic Acid
• 7.8. Vitamins
  • 7.8.1. Vitamin A
  • 7.8.2. Vitamin B
  • 7.8.3. Vitamin C
  • 7.8.4. Vitamin E
  • 7.8.5. Vitamin K

8. Medical Grade Skincare Market, by Packaging Type

• 8.1. Introduction
• 8.2. Bottle
• 8.3. Dispensing Pumps
• 8.4. Tube

9. Medical Grade Skincare Market, by Indication

• 9.1. Introduction
• 9.2. Acne
• 9.3. Age Spots
• 9.4. Dry Skin
• 9.5. Fine Lines & Winkles
• 9.6. Hyperpigmentation
• 9.7. Skin Laxity
• 9.8. Sun Damage

10. Medical Grade Skincare Market, by Distribution Channels

• 10.1. Introduction
• 10.2. Offline
  • 10.2.1. Dermatology Clinics
  • 10.2.2. Physicians
• 10.3. Online

11. Medical Grade Skincare Market, by Revenue Distribution

• 11.1. Introduction
• 11.2. Sell-in
• 11.3. Sell-out

12. Americas Medical Grade Skincare Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Medical Grade Skincare Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Medical Grade Skincare Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Shiseido to Acquire Dr. Dennis Gross Skincare
  • 15.3.2. Revision Skincare Unveils 'Science Is Black and White' Brand Campaign Alongside New Innovation
  • 15.3.3. Galderma Announces Launch in the UK and Direct Distribution and Expansion in Canada
  • 15.3.4. INSKIN COSMEDICS Secures Funding to Accelerate Growth
  • 15.3.5. Alumier Introduces its Latest Refining Clay Mask
  • 15.3.6. Skin Pharm Raises USD 15 Million To Expand Clinics, Scale Aesthetic Dermatology Practice
  • 15.3.7. Skin Rx Launches Preventive, Medical-Grade Skincare for Gen Z
  • 15.3.8. Hand & Stone Further Invests into Skin Care and Facial Enhancements
  • 15.3.9. GetHarley Raises USD 52 million to Connect Consumers With World-Class Clinicians and Medical-Grade Skincare Products
  • 15.3.10. AlumierMD Unveils New Wellness Assets
  • 15.3.11. UK-based Skin + Me secures over EUR 11 million for its Personalized Prescription-Based Approach To Skincare
  • 15.3.12. Evolve Med Spa Launches Medical-Grade Skincare Line

Companies Mentioned

• 1. Abbott Laboratories
• 2. ALASTIN Skincare, Inc. by Galderma Laboratories, L.P.
• 3. Alkem Laboratories Ltd.
• 4. AllerganAesthetics
• 5. Alpyn Beauty
• 6. AlumierMD Labs, Inc.
• 7. AMP Medical, LLC
• 8. Aspect Skincare by Advanced Skin Technology Pty Ltd.
• 9. Audaja Inc.
• 10. Augustinus Bader
• 11. Beiersdorf AG
• 12. Bioderma
• 13. Cipla Limited
• 14. Colgate-Palmolive Company
• 15. CosMedical Technologies
• 16. Cosmetic Solutions
• 17. DefenAge by Progenitor Biologics, LLC
• 18. DERMAdoctor, LLC by NovaBay Pharmaceuticals
• 19. Eau Thermale Avene by Pierre Fabre Group
• 20. Environ Skin Care (Pty) Ltd.
• 21. Epicutis
• 22. Episciences, Inc.
• 23. ESK Care Pty Limited
• 24. Estee Lauder Companies Inc.
• 25. Evolve Med Spa
• 26. GlaxoSmithKline PLC
• 27. Glenmark Pharmaceuticals Limited
• 28. Honasa Consumer Ltd.
• 29. Image Skincare
• 30. INSKIN Cosmedics Group Pty Ltd.
• 31. Inspira Skin
• 32. iS Clinical
• 33. Jan Marini Skin Research
• 34. L'Oreal S.A.
• 35. NEOCUTIS by Merz North America, Inc.
• 36. NeoStrata Company, Inc. by Johnson & Johnson Services, Inc.
• 37. Obagi Cosmeceuticals LLC
• 38. Piramal Pharma Limited
• 39. Revision Skincare
• 40. Sebapharma GmbH & CO. KG
• 41. Sente, Inc.
• 42. Shiseido Company, Limited
• 43. Skin + Me
• 44. The Skincare Company
• 45. Topix Pharmaceuticals, Inc.
• 46. Trilogy Laboratories, LLC
• 47. Unilever PLC
• 48. USRx LLC
• 49. ZO Skin Health, Inc.